18,000
Participants
Start Date
June 30, 2015
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
exenatide once weekly
patients received exenatide once weekly treatment under their standard care, no intervention was given by the study investigator
exenatide twice daily
patients with exenatide twice daily treatment under their standard care, no intervention was given by the study investigator.
basal insulin
patients with basal insulin treatment under their standard care, no intervention was given by the study investigator
Pharmatelligence, Cardiff
Lead Sponsor
AstraZeneca
INDUSTRY